Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
1.600
-0.140 (-8.05%)
At close: Dec 20, 2024, 4:00 PM
1.550
-0.050 (-3.13%)
After-hours: Dec 20, 2024, 7:01 PM EST
Mersana Therapeutics Market Cap
Mersana Therapeutics has a market cap or net worth of $197.65 million as of December 20, 2024. Its market cap has decreased by -19.65% in one year.
Market Cap
197.65M
Enterprise Value
74.01M
1-Year Change
-19.65%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since June 28, 2017, Mersana Therapeutics's market cap has decreased from $317.04M to $197.65M, a decrease of -37.66%. That is a compound annual growth rate of -6.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cardiff Oncology | 229.59M |
Nautilus Biotechnology | 226.02M |
Ocugen | 223.70M |
Alpha Tau Medical | 218.51M |
Fulcrum Therapeutics | 217.37M |
Precigen | 212.56M |
Inhibikase Therapeutics | 212.33M |
LifeMD | 212.23M |